AstraZeneca shares tumble 15% on big drug trial setback https://t.co/0otwvW1XpB via @FT
— The Propell Group (@ThePropellGroup) July 28, 2017
#healthtech
AstraZeneca shares tumble 15% on big drug trial setback https://t.co/0otwvW1XpB via @FT
— The Propell Group (@ThePropellGroup) July 28, 2017
#healthtech